Overview

Nasonex Compared With Placebo in Participants With Seasonal Allergic Rhinitis (SAR) and Concomitant Asthma (P03280)

Status:
Completed
Trial end date:
2003-11-26
Target enrollment:
Participant gender:
Summary
This study will compare mometasone nasal spray to placebo in treating the nasal and asthma symptoms experienced by participants with seasonal allergic rhinitis (SAR) and concomitant asthma.
Phase:
Phase 4
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Collaborator:
Integrated Therapeutics Group
Treatments:
Albuterol
Mometasone Furoate